Clinical Trial

Association Between Genetic Polymorphisms and Type 2 Asthma in Children

Study acronym: SNP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 21, 2025 (before its estimated December 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To further understand the role of gene single nucleotide polymorphism (SNP) in the occurrence of type 2 inflammation-related asthma in children by analyzing the gene single nucleotide polymorphism (SNP), lung function and type 2 inflammation indicators of children diagnosed with asthma in outpatient and inpatient. To provide a theoretical basis for the study of personalized treatment and prevention strategies for asthma.
Trial Details
NCT Number NCT06840717
Lead Sponsor Guangzhou Institute of Respiratory Disease
Conditions Asthma in Children, Genetic Disease, Inflammation
Enrollment 300 participants
Start Date 2024-01-30
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-02-21